Literature DB >> 34853157

CT pectoralis muscle area is associated with DXA lean mass and correlates with emphysema progression in a tobacco-exposed cohort.

Michael Emmet O'Brien1, Richard H Zou1, Nathan Hyre2, Joseph K Leader3, Carl R Fuhrman3, Frank C Sciurba1, Mehdi Nouraie1, Jessica Bon4.   

Abstract

INTRODUCTION: Muscle loss is an important extrapulmonary manifestation of COPD. Dual energy X-ray absorptiometry (DXA) is the method of choice for body composition measurement but is not widely used for muscle mass evaluation. The pectoralis muscle area (PMA) is quantifiable by CT and predicts cross-sectional COPD-related morbidity. There are no studies that compare PMA with DXA measures or that evaluate longitudinal relationships between PMA and lung disease progression.
METHODS: Participants from our longitudinal tobacco-exposed cohort had baseline and 6-year chest CT (n=259) and DXA (n=164) data. Emphysema was quantified by CT density histogram parenchymal scoring using the 15th percentile technique. Fat-free mass index (FFMI) and appendicular skeletal mass index (ASMI) were calculated from DXA measurements. Linear regression model relationships were reported using standardised coefficient (β) with 95% CI.
RESULTS: PMA was more strongly associated with DXA measures than with body mass index (BMI) in both cross-sectional (FFMI: β=0.76 (95% CI 0.65 to 0.86), p<0.001; ASMI: β=0.76 (95% CI 0.66 to 0.86), p<0.001; BMI: β=0.36 (95% CI 0.25 to 0.47), p<0.001) and longitudinal (ΔFFMI: β=0.43 (95% CI 0.28 to 0.57), p<0.001; ΔASMI: β=0.42 (95% CI 0.27 to 0.57), p<0.001; ΔBMI: β=0.34 (95% CI 0.22 to 0.46), p<0.001) models. Six-year change in PMA was associated with 6-year change in emphysema (β=0.39 (95% CI 0.23 to 0.56), p<0.001) but not with 6-year change in airflow obstruction.
CONCLUSIONS: PMA is an accessible measure of muscle mass and may serve as a useful clinical surrogate for assessing skeletal muscle loss in smokers. Decreased PMA correlated with emphysema progression but not lung function decline, suggesting a difference in the pathophysiology driving emphysema, airflow obstruction and comorbidity risk. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  emphysema; imaging/CT MRI etc; respiratory muscles; tobacco and the lung

Year:  2021        PMID: 34853157      PMCID: PMC9156725          DOI: 10.1136/thoraxjnl-2021-217710

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.102


  38 in total

1.  Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency.

Authors:  D G Parr; B C Stoel; J Stolk; R A Stockley
Journal:  Thorax       Date:  2006-03-14       Impact factor: 9.139

2.  Chronic Respiratory Symptoms with Normal Spirometry. A Reliable Clinical Entity?

Authors:  Roberto Rodriguez-Roisin; MeiLan K Han; Jørgen Vestbo; Jadwiga A Wedzicha; Prescott G Woodruff; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2017-01-01       Impact factor: 21.405

3.  Body composition by DXA.

Authors:  John A Shepherd; Bennett K Ng; Markus J Sommer; Steven B Heymsfield
Journal:  Bone       Date:  2017-06-16       Impact factor: 4.398

4.  Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort.

Authors:  Jessica Bon; Carl R Fuhrman; Joel L Weissfeld; Steven R Duncan; Robert A Branch; Chung-Chou H Chang; Yingze Zhang; Joseph K Leader; David Gur; Susan L Greenspan; Frank C Sciurba
Journal:  Am J Respir Crit Care Med       Date:  2010-10-08       Impact factor: 21.405

5.  Body mass index and the risk of COPD.

Authors:  Raida I Harik-Khan; Jerome L Fleg; Robert A Wise
Journal:  Chest       Date:  2002-02       Impact factor: 9.410

6.  Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease.

Authors:  Karine Marquis; Richard Debigaré; Yves Lacasse; Pierre LeBlanc; Jean Jobin; Guy Carrier; François Maltais
Journal:  Am J Respir Crit Care Med       Date:  2002-09-15       Impact factor: 21.405

7.  The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study.

Authors:  Bret H Goodpaster; Seok Won Park; Tamara B Harris; Steven B Kritchevsky; Michael Nevitt; Ann V Schwartz; Eleanor M Simonsick; Frances A Tylavsky; Marjolein Visser; Anne B Newman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-10       Impact factor: 6.053

Review 8.  Clinical applications of body composition measurements using DXA.

Authors:  Carlina V Albanese; Evelyn Diessel; Harry K Genant
Journal:  J Clin Densitom       Date:  2003       Impact factor: 2.963

9.  The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study.

Authors:  Harvey O Coxson; Asger Dirksen; Lisa D Edwards; Julie C Yates; Alvar Agusti; Per Bakke; Peter Ma Calverley; Bartolome Celli; Courtney Crim; Annelyse Duvoix; Paola Nasute Fauerbach; David A Lomas; William Macnee; Ruth J Mayer; Bruce E Miller; Nestor L Müller; Stephen I Rennard; Edwin K Silverman; Ruth Tal-Singer; Emiel Fm Wouters; Jørgen Vestbo
Journal:  Lancet Respir Med       Date:  2013-02-01       Impact factor: 30.700

10.  BMI is associated with FEV1 decline in chronic obstructive pulmonary disease: a meta-analysis of clinical trials.

Authors:  Yilan Sun; Stephen Milne; Jen Erh Jaw; Chen Xi Yang; Feng Xu; Xuan Li; Ma'en Obeidat; Don D Sin
Journal:  Respir Res       Date:  2019-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.